FDA Inspection 1041003 — Emergent Biodefense Operations Lansing LLC
The FDA completed an inspection of Emergent Biodefense Operations Lansing LLC on December 21, 2017 in Canton, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 21, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Canton, MA (United States)